Main Article Content


Onychomycosis is a fungal infection of the nails that can be caused by dermatophytes, non-dermatophytes, and yeast, while tinea unguium is an infection of the nails caused by the dermatophyte group. Onychomycosis is known to occur in 2-18.5% of the population worldwide where it is 4-20 times more common in toenails than fingernails. In patients with systemic lupus erythematosus, it was reported that 25% experienced nail changes where the most common abnormality was onycholysis. The following is a report of a 27-year-old female patient with complaints of damaged and brittle left toe nails accompanied by itching. From the dermatological examination of the left I-V digiti pedis, discoloration and onychodystrophy were found. Examination of 20% KOH on nail clippings shows long-branched hyphae. The results of the fungal culture showed the growth of Microsporum sp. This case report discusses a rare  case of tinea unguium caused by Microsporum sp.

Article Details

How to Cite
Saviestya, K. B., & Widasmara, D. (2024). Tinea Unguium Caused by Microsporum sp. : A Rare Case. Jurnal Klinik Dan Riset Kesehatan, 3(2), 137-143.


Lauren N. Craddock & Stefan M. Schieke. Fitz-patrick’s Dermatology 9th edition. Kang S et al, editor. Mc Graw-Hill Education; 2019. 2959–2983 hal.
2. Fike JM, Kollipara R, Alkul S, Stetson CL. Case report of onychomycosis and tinea corporis due to microsporum gypseum. J Cutan Med Surg. 2018;22(1):94–6.
3. Akpinar Kara Y. The change of causative patho-gens in toenail onychomycosis. J Cosmet Derma-tol. 2021;20(7):2311–6.
4. Gupta AK, Stec N, Summerbell RC, Shear NH, Piguet V, Tosti A, et al. Onychomycosis: a review. J Eur Acad Dermatology Venereol. 2020;34(9):1972–90.
5. Tlacuilo-Parra A, Guevara-Gutierrez E, Mayorga J, Garcia-De La Torre I, Salazar-Paramo M. Ony-chomycosis in systemic lupus erythematosus: A case control study. J Rheumatol. 2003;30(7):1491–4.
6. Chang P, Ucelo ZMQ, del Pilar Garzaro Chávez HM. Onychomycosis and Immunodepression. Curr Fungal Infect Rep. 2017;11(4):252–7.
7. Lipner SR, Scher RK. Onychomycosis: Clinical overview and diagnosis. J Am Acad Dermatol. 2019;80(4):835–51.
8. Gupta AK, Mays RR, Versteeg SG, Piraccini BM, Takwale A, Shemer A, et al. Global perspectives for the management of onychomycosis. Int J Dermatol. 2019;58(10):1118–29.
9. Lipner SR. Pharmacotherapy for onychomyco-sis: new and emerging treatments. Expert Opin Pharmacother [Internet]. 2019;20(6):725–35.
10. Marrack P, Kappler J, Kotzin BL. Autoimmune disease: Why and where it occurs. Nat Med. 2001;7(8):899–905.
11. Velasquez-Agudelo V, Cardona-Arias JA. Meta-analysis of the utility of culture, biopsy, and direct KOH examination for the diagnosis of onychomycosis. BMC Infect Dis. 2017;17(1):1–11.
12. Monod M, Méhul B. Recent findings in ony-chomycosis and their application for appropri-ate treatment. J Fungi. 2019;5(1).
13. Grover C, Khurana A. Onychomycosis: Newer insights in pathogenesis and diagnosis. Indian J Dermatol Venereol Leprol. 2012;78(3):263–70.
14. Lipner SR, Scher RK. Onychomycosis: Treatment and prevention of recurrence. J Am Acad Dermatol. 2019;80(4):853–67.
15. Asz-Sigall D, Tosti A, Arenas R. Tinea Unguium: Diagnosis and Treatment in Practice. Mycopathologia. 2017;182(1–2):95–100.